Table 1. Anthropometric and laboratory parameters of the study-population.

	Before DHATreatment	After DHAtreatment	Paired-samplesT Test (p-value)
Sex (M/F)	11/9	11/9	–
Age (years)	10.1±2.0	12.3±2.0	<0.001*
Weight (kg)	57.1±9.9	59.8±9.9	<0.001*
Height (cm)	151±17	165±16	<0.001*
BMI (kg/m2)	26.1±2.5	25.63±2.2	0.072
Cholesterol (mg/dL)	172.1±11.2	169.6±12.9	0.729
Triglycerides (mg/dL)	91.9±30.1	78.8±17.7	0.048*
ALT (U/L)	65.4±21.3	38.9±6.2	0.001*
AST (U/L)	50.0±15.7	35.4±5.8	0.007*
GGT (U/L)	21.3±5.6	19.1±3.1	0.204
Glucose (mg/dL)	84.9±6.7	86.6±3.7	0.328
Insulin (µU/mL)	14.7±8.1	12.0±4.8	0.057
HOMA-IR	3.1±1.8	2.5±1.0	0.089
ISI	3.0±0.5	3.4±0.5	0.038*
TNF-alpha (pg/mL)	19.85±3.32	5.89±2.09	<0.001*
IL-6 (pg/mL)	12.55±1.32	5.85±2.23	<0.001*
IL-1B (pg/mL)	25.10±1.46	8.87±2.86	<0.001*
US	2.6±0.5	1.3±0.6	<0.001*

Data are reported as Means ± SD * = p<0.05.